---
company: NORTECH SYSTEMS INC
ticker: NSYS
form: 8-K
filed: 2026-08-12
accession: 0001493152-26-037337
source: https://www.sec.gov/Archives/edgar/data/722313/000149315226037337/
---

# Nortech Systems (NSYS) earnings release, August 12, 2026

Nortech Systems Inc (NSYS) · Form 8-K, Item 2.02 · Filed 2026-08-12 · [SEC filing](https://www.sec.gov/Archives/edgar/data/722313/000149315226037337/)

Nortech Systems Reports Second Quarter Results

MINNEAPOLIS – August 12, 2026 – Nortech

Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace

& defense markets, reported financial results for the second quarter ended June 30, 2026.

2026 Q2 Highlights:

Management Commentary

“Nortech delivered a solid second quarter, with year-over-year revenue growth, improved gross margins, and continued positive operating income reflecting the benefits of our restructuring actions and disciplined execution,” said President & CEO, Jay D. Miller.

“We are encouraged by the continued strength of our bookings and our backlog, which we view as an important leading indicator of future business prospects, including opportunities in attractive markets such as Aerospace and Defense as well as Medical.

We are also seeing continued customer interest in nearshoring and regional manufacturing strategies, where our North American footprint, combined with our China operations, positions Nortech well to support customers’ evolving supply chain needs. As we move through the second half of 2026, we remain focused on converting strong customer engagement into sustainable growth and long-term value.”

Summary Financial Information

The following table provides summary financial information comparing the second quarter 2026 (“Q2 2026”) financial results to the same quarter in 2025 (“Q2 2025”) as well as the six-month period ended June 30, 2026 (“YTD 2026”) with the same period in 2025 (“YTD 2025”).

Conference Call

The Company will hold a live conference call and webcast at 3:30 p.m. central time on Wednesday, August 12, to discuss the Company’s 2026 second quarter results.

The call will be hosted by Jay D. Miller, Chief Executive Officer and President and Andrew D. C. LaFrence, Chief Financial Officer and

Senior Vice President of Finance. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 979013. Participants may also access the call via webcast at: https://www.webcaster5.com/Webcast/Page/2814/54239.

###

About Nortech Systems

Incorporated

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components.

Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock

Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform

Act of 1995 including without limitation statements regarding strength and growth of bookings and backlog, future business prospects, opportunities in aerospace and defense and medical markets, converting strong customer engagement into sustainable growth and long-term value, future financial results including increased gross margin, our ability to generate positive EBITDA, nearshoring as a strategic advantage, successful execution of our long-term strategy, our enhanced competitiveness in aerospace, defense, and other high-reliability markets, and effects of restructuring and consolidating manufacturing facilities. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties.

Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

(1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components; (3) volatility in market conditions which may affect demand for the Company’s products;

(4) increased competition and/or reduced demand; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions including changing tariff environment; (9) the Company’s ability to steadily improve manufacturing output and product quality; (10) the impact of global health epidemics on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition; (11) challenges with customers with respect to moving production from one facility to another Company owned facility or (12) financing cost increases and continued availability. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial... (truncated)ng the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

Reconciliation of Generally Accepted Accounting

Principles (“GAAP”) Measures to Non-GAAP Financial Measure

EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Adjusted EBITDA reflects the impact of restructuring and non-recurring items. EBITDA and Adjusted EBITDA are not a measurement of our financial performance under

GAAP and should not be considered an alternative to net sales or net income (loss), as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA and Adjusted EBITDA have limitations as an analytical metric, and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.

## Financial statements

### Income Statement (in thousands)

| | Q2 2026 | Q2 2025 | % Change | YTD 2026 | YTD 2025 | % Change |
|---|---:|---:|---:|---:|---:|---:|
| Net sales | 33,540 | 30,675 | 9.3% | 63,856 | 57,570 | 10.9% |
| Gross profit | 5,703 | 4,837 | 17.9% | 10,405 | 7,915 | 31.5% |
| Operating expenses | 5,080 | 4,095 | 24.1% | 9,735 | 8,786 | 10.8% |
| Net income (loss) | 316 | 313 | 1.0% | 282 | -1,003 | -128.1% |
| EBITDA | 938 | 1,073 | -12.6% | 1,288 | -193 | -767.4% |
| Adjusted EBITDA | 938 | 1,073 | -12.6% | 1,288 | 73 | 1664.0% |

### Income Statement (THREE MONTHS ENDED — (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA))

| | THREE MONTHS ENDED – JUNE 30, – 2026 | THREE MONTHS ENDED – JUNE 30, – 2025 | SIX MONTHS ENDED – JUNE 30, – 2026 | SIX MONTHS ENDED – JUNE 30, – 2025 |
|---|---:|---:|---:|---:|
| Net sales | 33,540 | 30,675 | 63,856 | 57,570 |
| Cost of goods sold | 27,837 | 25,838 | 53,451 | 49,655 |
| Gross profit | 5,703 | 4,837 | 10,405 | 7,915 |
| Operating expenses: | Selling | 1,484 | 1,204 | 2,815 | 2,388 |
| Operating expenses: | General and administrative | 3,250 | 2,589 | 6,264 | 5,504 |
| Operating expenses: | Research and development | 346 | 302 | 656 | 628 |
| Operating expenses: | Restructuring charges |  |  |  | 266 |
| Operating expenses: | Total operating expenses | 5,080 | 4,095 | 9,735 | 8,786 |
| Operating expenses: | Income (loss) from operations | 623 | 742 | 670 | -871 |
| Other expense: | Interest expense, net | -197 | -257 | -453 | -471 |
| Other expense: | Income (loss) before income taxes | 426 | 485 | 217 | -1,342 |
| Other expense: | Income tax expense (benefit) | 110 | 172 | -65 | -339 |
| Other expense: | Net income (loss) | 316 | 313 | 282 | -1,003 |
| Net income (loss) per common share: | Basic (in dollars per share) | 0.11 | 0.12 | 0.1 | -0.36 |
| Net income (loss) per common share: | Weighted average number of common shares outstanding - basic (in shares) | 2,805,183 | 2,773,598 | 2,795,659 | 2,767,263 |
| Net income (loss) per common share: | Diluted (in dollars per share) | 0.11 | 0.12 | 0.09 | -0.36 |
| Net income (loss) per common share: | Weighted average number of common shares outstanding - diluted (in shares) | 2,999,002 | 2,954,765 | 3,007,439 | 2,767,263 |
| Other comprehensive income (loss) | Foreign currency translation | 21 | 124 | 90 | 130 |
| Other comprehensive income (loss) | Comprehensive income (loss), net of tax | 337 | 437 | 372 | -873 |

### Income Statement (in millions)

| | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2023 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q3 2023 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q4 2023 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q1 2024 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2024 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q3 2024 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q4 2024 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q1 2025 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2025 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q3 2025 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q4 2025 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q1 2026 | Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2026 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Net Sales | 140.8 | 138.9 | 139.3 | 138.7 | 137.5 | 135.6 | 128.1 | 120.8 | 117.6 | 116.7 | 118.4 | 121.8 | 124.7 |
| Gross Profit $ - Adjusted | 22.4 | 21.4 | 23.1 | 23.1 | 22.2 | 20.7 | 16.7 | 14.4 | 14.6 | 15.8 | 18 | 19.6 | 20.5 |
| Gross Margin % - Adjusted | 15.9 | 15.4 | 16.6 | 16.6 | 16.1 | 15.3 | 13.1 | 11.9 | 12.4 | 13.5 | 15.2 | 16.1 | 16.4 |
| EBITDA - Adjusted | 6.8 | 6 | 8 | 8.1 | 7.3 | 5.9 | 2.1 | -0.5 | -0.4 | 0.7 | 2.5 | 3.9 | 3.7 |

### Balance Sheet (JUNE 30, 2026 — (IN THOUSANDS, EXCEPT SHARE DATA))

| | JUNE 30, 2026 | DECEMBER 31, 2025 |
|---|---:|---:|
| Current assets: | Cash | 1,380 | 1,655 |
| Current assets: | Restricted cash | 294 |  |
| Current assets: | Accounts receivable, less allowance for credit losses of $154 and $161, respectively | 19,850 | 16,998 |
| Current assets: | Inventories, net | 24,512 | 20,695 |
| Current assets: | Contract assets | 16,979 | 15,184 |
| Current assets: | Prepaid assets and other assets | 1,279 | 1,618 |
| Current assets: | Total current assets | 64,294 | 56,150 |
| Current assets: | Property and equipment, net | 4,977 | 5,203 |
| Current assets: | Operating lease assets, net | 6,420 | 7,016 |
| Current assets: | Deferred tax assets | 3,963 | 3,394 |
| Current assets: | Other intangible assets, net | 147 | 156 |
| Current assets: | Deferred line of credit issuance costs, net | 244 |  |
| Current assets: | Total assets | 80,045 | 71,919 |
| Current liabilities: | Lines of credit | 7,868 | 7,000 |
| Current liabilities: | Current portion of term loan, net of debt issuance costs | 432 |  |
| Current liabilities: | Accounts payable | 14,949 | 12,809 |
| Current liabilities: | Accrued payroll and commissions | 2,808 | 1,822 |
| Current liabilities: | Customer deposits | 6,848 | 5,386 |
| Current liabilities: | Current portion of operating leases | 1,246 | 1,332 |
| Current liabilities: | Current portion of finance lease obligations | 243 | 274 |
| Current liabilities: | Other accrued liabilities | 1,644 | 1,221 |
| Current liabilities: | Total current liabilities | 36,038 | 29,844 |
| Long-term liabilities: | Term loan, net of debt issuance costs | 1,636 |  |
| Long-term liabilities: | Long-term operating lease obligations | 5,929 | 6,476 |
| Long-term liabilities: | Long-term finance lease obligations | 534 | 626 |
| Long-term liabilities: | Other long-term liabilities | 434 | 426 |
| Long-term liabilities: | Total long-term liabilities | 8,533 | 7,528 |
| Long-term liabilities: | Total liabilities | 44,571 | 37,372 |
| Shareholders’ equity: | Preferred stock, $1 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding | 250 | 250 |
| Shareholders’ equity: | Common stock - $0.01 par value; 9,000,000 shares authorized; 2,853,766 and 2,786,134 shares issued and outstanding, respectively | 29 | 28 |
| Shareholders’ equity: | Additional paid-in capital | 18,409 | 17,855 |
| Shareholders’ equity: | Accumulated other comprehensive loss | -619 | -709 |
| Shareholders’ equity: | Retained earnings | 17,405 | 17,123 |

### Cash Flow (SIX MONTHS ENDED JUNE 30, — (IN THOUSANDS) (in thousands))

| | SIX MONTHS ENDED JUNE 30, – 2026 | SIX MONTHS ENDED JUNE 30, – 2025 |
|---|---:|---:|
| CASH FLOWS FROM OPERATING ACTIVITIES | Net income (loss) | 282 | -1,003 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | Depreciation and amortization | 618 | 678 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | Compensation on stock-based awards | 320 | 235 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | Change in allowance for credit losses | -7 | 10 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | Change in inventory reserves | -311 | 351 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | Deferred taxes | -569 | -700 |
| Changes in current operating items: | Accounts receivable | -2,705 | -2,842 |
| Changes in current operating items: | Inventories | -3,530 | 2,714 |
| Changes in current operating items: | Contract assets | -1,795 | -1,192 |
| Changes in current operating items: | Prepaid expenses and other assets | 338 | -1,647 |
| Changes in current operating items: | Accounts payable | 2,077 | 295 |
| Changes in current operating items: | Accrued payroll and commissions | 978 | -94 |
| Changes in current operating items: | Customer deposits | 1,463 | 36 |
| Changes in current operating items: | Other accrued liabilities | 392 | 386 |
| Changes in current operating items: | Net cash used in operating activities | -2,449 | -2,773 |
| CASH FLOWS FROM INVESTING ACTIVITIES | Proceeds from sale of property and equipment |  | 9 |
| CASH FLOWS FROM INVESTING ACTIVITIES | Purchases of property and equipment | -323 | -367 |
| CASH FLOWS FROM INVESTING ACTIVITIES | Net cash used in investing activities | -323 | -358 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Proceeds from lines of credit | 35,061 | 51,405 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Payments to line of credit | -34,198 | -48,485 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Proceeds from term loan | 2,200 |  |
| CASH FLOWS FROM FINANCING ACTIVITIES | Payments of debt issuance costs | -290 |  |
| CASH FLOWS FROM FINANCING ACTIVITIES | Principal payments on term loan | -110 |  |
| CASH FLOWS FROM FINANCING ACTIVITIES | Principal payments on financing leases | -124 | -85 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Stock award exercises | 235 | 23 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Net cash provided by financing activities | 2,774 | 2,858 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Effect of exchange rate changes on cash and restricted cash | 17 | 9 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Net change in cash and restricted cash | 19 | -264 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Cash and restricted cash - beginning of period | 1,655 | 916 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Cash and restricted cash - end of period | 1,674 | 652 |
